SUTRO BIOPHARMA INC COM
SUTRO BIOPHARMA INC COM is a security (CUSIP 869367102) tracked across SEC portfolio filings. 9 institutional managers reported $6.8M on Form 13F as of 2026-06-30; 1 registered fund positions totaling $103K via N-PORT as of 2022-09-30.
Summary
- Issuer: SUTRO BIOPHARMA INC
- Class: COM
- CUSIP: 869367102
- Asset category: EC
- 13F holders: 9
- 13F value: $6.8M
- 13F period: 2026-06-30
- N-PORT fund positions: 1
- N-PORT value: $103K
- N-PORT report: 2022-09-30
Top institutional holders (Form 13F)
| Manager | Location | Value | Shares |
|---|
| Merck & Co., Inc. | RAHWAY, NJ | $6.8M | 272,351 |
| Point72 Asia (Singapore) Pte. Ltd. | SINGAPORE, U0 | $27K | 31,026 |
| Fortitude Family Office, LLC | SCOTTSDALE, AZ | $2K | 56 |
| Bogart Wealth, LLC | MCLEAN, VA | $2K | 50 |
| Parallel Advisors, LLC | SAN FRANCISCO, CA | $2K | 47 |
| Accredited Wealth Management, LLC | LOUISVILLE, KY | $869 | 5 |
| Advisory Services Network, LLC | Atlanta, GA | $374 | 15 |
| Cubist Systematic Strategies, LLC | Stamford, CT | $9 | 10 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |
Top fund holders (N-PORT)
More